Oncimmune Holdings (GB:ONC) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Oncimmune Holdings has secured three new contracts valued at £0.34 million, building on its recent commercial success of £2.14 million in contracts over the past three months. The deals with top global pharmaceutical companies highlight Oncimmune’s growing reputation and ability to secure repeat business. As the company progresses, it remains on track to meet its FY2025 revenue targets, showcasing its potential for profitability.
For further insights into GB:ONC stock, check out TipRanks’ Stock Analysis page.